Forest Laboratories, Inc. (FRX)

Company Overview
Forest Laboratories, Inc. and its subsidiaries, engage in the development, manufacture, and sale of branded and generic forms of ethical drug products, as well as nonprescription pharmaceutical products. Its principal products include Lexapro, a single isomer version of Celexa for the treatment of major depression; Namenda, a NMDA antagonist for the treatment of moderate to severe Alzheimer's disease; Benicar, an angiotensin receptor blocker for the treatment of hypertension; Campral for the maintenance of alcohol abstinence; and Combunox for the short-term management of acute, and moderate-to-severe pain. The company also offers Sudocrem, a topical preparation for the treatment of diaper...
read more

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 909 Third Avenue, New York, NY 10022-4731, United States
Mailing Address: -
Phone: 212-421-7850
Fax: 212-750-9152
Website: http//www.frx.com

Company Details:

Symbol: FRX
SIC: 2834
State location: NY
Sector: -
State of Inc: DE
Employees: 5200
Type: -

Key executives:

Name Age Position
Elaine Hochberg 59 Sr. VP Marketing and Member of Disclosure, Legal Compliance & Risk Management Committee
Francis I. Perier Jr. 56 Chief Financial Officer, Sr. VP of Fin., Principal Accounting Officer and Member of Disclosure, Legal Compliance & Risk Management Committee
Howard Solomon 88 Chairman and Chief Exec. Officer
Ivan Gergel M.D 56 Exec. VP of Scientific Affairs, Member of Disclosure, Legal Compliance & Risk Management Committee and Pres of Forest Research Institute
Raymond Stafford 2016 Exec. VP